{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:51:43Z","timestamp":1776765103836,"version":"3.51.2"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1093\/alcalc\/agl007","type":"journal-article","created":{"date-parts":[[2006,2,9]],"date-time":"2006-02-09T01:34:11Z","timestamp":1139448851000},"page":"321-327","source":"Crossref","is-referenced-by-count":66,"title":["COMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY"],"prefix":"10.1093","volume":"41","author":[{"given":"GERALD F. X.","family":"FEENEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JASON P.","family":"CONNOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROSS McD.","family":"YOUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANE","family":"TUCKER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNIE","family":"McPHERSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,2,8]]},"reference":[{"key":"key\n\t\t\t\t20171010160222_B1","doi-asserted-by":"crossref","unstructured":"Allen, J. P., Sillamaukee, P. and Anton R. (1999) Contribution of carbohydrate deficient transferrin to gamma glutamyl transpepsidase in evaluating progress of patients in treatment for alcoholism. Alcoholism: Clinical and Experimental Research23, 115\u2013120.","DOI":"10.1111\/j.1530-0277.1999.tb04031.x"},{"key":"key\n\t\t\t\t20171010160222_B2","unstructured":"Bouza, C., Magro, A., Munoz, A. et al. (2004) Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction99, 811\u2013828."},{"key":"key\n\t\t\t\t20171010160222_B3","doi-asserted-by":"crossref","unstructured":"COMBINE Study Research Group. (2003) Testing combined pharmacotherapies and behavioural interventions in alcohol dependence. Alcoholism: Clinical Experimental Research37, 1107\u20131122.","DOI":"10.1111\/j.1530-0277.2003.tb02873.x"},{"key":"key\n\t\t\t\t20171010160222_B4","doi-asserted-by":"crossref","unstructured":"COMBINE Study Research Group. (2003) Testing combined pharmacotherapies and behavioural interventions in alcohol dependence (The COMBINE Study): A pilot feasibility study. Alcoholism: Clinical and Experimental Research27, 1123\u20131131.","DOI":"10.1097\/01.ALC.0000078020.92938.0B"},{"key":"key\n\t\t\t\t20171010160222_B5","doi-asserted-by":"crossref","unstructured":"Feeney, G. F. X., Young, R. McD., Connor, J. P. et al. (2001) Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome. Australian and New Zealand Journal of Psychiatry35, 443\u2013449.","DOI":"10.1046\/j.1440-1614.2001.00935.x"},{"key":"key\n\t\t\t\t20171010160222_B6","doi-asserted-by":"crossref","unstructured":"Feeney, G. F., Connor, J. P., Young, R. McD. et al. (2001) Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation program. Journal of Clinical Pharmacy and Therapeutics26, 73\u201379.","DOI":"10.1046\/j.1365-2710.2001.00326.x"},{"key":"key\n\t\t\t\t20171010160222_B7","doi-asserted-by":"crossref","unstructured":"Feeney, G. F. X., Young, R. McD., Connor, J. P. et al. (2002) Cognitive behavioural therapy with relapse prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved? Australian and New Zealand Journal of Psychiatry36, 622\u2013628.","DOI":"10.1046\/j.1440-1614.2002.01019.x"},{"key":"key\n\t\t\t\t20171010160222_B8","doi-asserted-by":"crossref","unstructured":"Johnson, B. A., O'Malley, S. S., Ciraulo, D. A. et al. (2003) Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Journal of Clinical Psychopharmacology23, 281\u2013293.","DOI":"10.1097\/01.jcp.0000084029.22282.bb"},{"key":"key\n\t\t\t\t20171010160222_B9","doi-asserted-by":"crossref","unstructured":"Kiefer, F., Jahn, H., Tarnaske, T. et al. (2003) Comparing and combining Naltrexone and Acamprosate in relapse prevention of alcoholism. Archives of General Psychiatry60, 92\u201399.","DOI":"10.1001\/archpsyc.60.1.92"},{"key":"key\n\t\t\t\t20171010160222_B10","doi-asserted-by":"crossref","unstructured":"Lhuintre, J. P., Moore, N., Tran, G. et al. (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism25, 613\u2013622.","DOI":"10.1093\/oxfordjournals.alcalc.a045057"},{"key":"key\n\t\t\t\t20171010160222_B11","doi-asserted-by":"crossref","unstructured":"Littleton, J. (1995) Acamprosate in alcohol dependence: how does it work? Addiction90, 1179\u20131188.","DOI":"10.1111\/j.1360-0443.1995.tb01088.x"},{"key":"key\n\t\t\t\t20171010160222_B12","doi-asserted-by":"crossref","unstructured":"Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcoholism: Clinical and Experimental Research28, 51\u201363.","DOI":"10.1097\/01.ALC.0000108656.81563.05"},{"key":"key\n\t\t\t\t20171010160222_B13","doi-asserted-by":"crossref","unstructured":"Mason, B. J. (2003) Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. European Neuropsychopharmacology13, 469\u2013475.","DOI":"10.1016\/j.euroneuro.2003.08.009"},{"key":"key\n\t\t\t\t20171010160222_B14","doi-asserted-by":"crossref","unstructured":"Mason, B. J., Goodman, A. M., Dixon, R. M. et al. (2002) A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology27, 596\u2013606.","DOI":"10.1016\/S0893-133X(02)00368-8"},{"key":"key\n\t\t\t\t20171010160222_B15","doi-asserted-by":"crossref","unstructured":"Myrick, H. and Anton, R. (2004) Recent advances in pharmacotherapy of alcoholism. Current Psychiatry Reports6, 332\u2013338.","DOI":"10.1007\/s11920-004-0019-7"},{"key":"key\n\t\t\t\t20171010160222_B16","doi-asserted-by":"crossref","unstructured":"O'Malley, S., Jaffe, S., Chang, G. et al. (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry49, 881\u2013887.","DOI":"10.1001\/archpsyc.1992.01820110045007"},{"key":"key\n\t\t\t\t20171010160222_B17","doi-asserted-by":"crossref","unstructured":"Pelc, I., LeBon, O., Verbanck, P. et al. (1992) Calcium-acetylhomotaurine for maintaining abstinence in weaned alcoholic patients: a placebo-controlled double-blind multicenter study. In Novel Pharmacological Interventions for Alcoholism. Naranjo, C. A. and Sellers, E. M. eds, pp. 348\u2013352. Springer Verlag, New York.","DOI":"10.1007\/978-1-4612-2878-3_44"},{"key":"key\n\t\t\t\t20171010160222_B18","doi-asserted-by":"crossref","unstructured":"Pokorny, A. D., Miller, B. A. and Kaplan, H. B. (1972) The brief MAST: a shortened version of the Michigan Alcoholism Screening Test. American Journal of Psychiatry129, 342\u2013345.","DOI":"10.1176\/ajp.129.3.342"},{"key":"key\n\t\t\t\t20171010160222_B19","unstructured":"Sobell, L. C. and Sobell, M. B. (1996) Alcohol Timeline Followback (TLFB) Users Manual. Toronto, Canada: Addiction Research Foundation."},{"key":"key\n\t\t\t\t20171010160222_B20","doi-asserted-by":"crossref","unstructured":"Volpicelli, J. R., Alterman, A. I., Hayashida, M. et al. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry49, 876\u2013880.","DOI":"10.1001\/archpsyc.1992.01820110040006"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/41\/3\/321\/211742\/agl007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T21:04:03Z","timestamp":1555448643000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/alcalc\/article\/41\/3\/321\/93225\/COMBINED-ACAMPROSATE-AND-NALTREXONE-WITH-COGNITIVE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,8]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,2,8]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agl007","relation":{},"ISSN":["1464-3502","0735-0414"],"issn-type":[{"value":"1464-3502","type":"electronic"},{"value":"0735-0414","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,5]]},"published":{"date-parts":[[2006,2,8]]}}}